350 related articles for article (PubMed ID: 6275986)
1. Methotrexate in the chemotherapy of lung cancer.
Smyth JF; Ford HT
Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
[TBL] [Abstract][Full Text] [Related]
2. Upper hemibody and local chest irradiation as consolidation following response to high-dose induction chemotherapy for small cell bronchogenic carcinoma--a pilot study.
Mason BA; Richter MP; Catalano RB; Creech RB
Cancer Treat Rep; 1982 Aug; 66(8):1609-12. PubMed ID: 6286119
[TBL] [Abstract][Full Text] [Related]
3. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
Aisner J; Whitacre M; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
[TBL] [Abstract][Full Text] [Related]
5. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
[TBL] [Abstract][Full Text] [Related]
6. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
[TBL] [Abstract][Full Text] [Related]
7. Intensive chemotherapy of small cell bronchogenic carcinoma.
Cohen MH; Creaven PJ; Fossieck BE; Broder LE; Selawry OS; Johnston AV; Williams CL; Minna JD
Cancer Treat Rep; 1977; 61(3):349-54. PubMed ID: 194691
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
[TBL] [Abstract][Full Text] [Related]
9. Three-drug chemotherapy combined with radiation therapy in small cell carcinoma of the lung.
Sibille Y; Steyaert J; Francis C; Bosly A; Prignot J
Eur J Respir Dis; 1983 Feb; 64(2):113-20. PubMed ID: 6299770
[TBL] [Abstract][Full Text] [Related]
10. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide.
Bonomi P; O'Reilly W; Vogl SE; Ruckdeschel JC; Stolbach L; Bunting N; Creech RH
Cancer Treat Rep; 1985 Sep; 69(9):1007-9. PubMed ID: 2992783
[TBL] [Abstract][Full Text] [Related]
11. Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung.
Davis S; Pandya MR; Rambotti P
Cancer Treat Rep; 1980; 64(4-5):685-8. PubMed ID: 6253067
[TBL] [Abstract][Full Text] [Related]
12. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
Poplin EA; Aisner J; Van Echo DA; Whitacre M; Wiernik PH
Cancer Treat Rep; 1982 Jul; 66(7):1557-9. PubMed ID: 6284360
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II.
Ruckdeschel JC; Mehta CR; Salazar OM; Cohen M; Vogl S; Koons LS; Lerner H
Cancer Treat Rep; 1981; 65(11-12):965-72. PubMed ID: 7028258
[TBL] [Abstract][Full Text] [Related]
17. Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy.
Harper PG; Souhami RL; Spiro SG; Geddes DM; Guimaraes M; Fearon F; Smyth JF
Cancer Treat Rep; 1982 Mar; 66(3):463-70. PubMed ID: 6277486
[TBL] [Abstract][Full Text] [Related]
18. [Adriamycin in the combined chemotherapy of small-cell lung cancer].
Perevodchikova NI; Bychkov MB; Ausekar BV
Antibiotiki; 1983 Aug; 28(8):628-32. PubMed ID: 6314882
[TBL] [Abstract][Full Text] [Related]
19. Small cell anaplastic carcinoma of the lung. The Cancer and Leukemia Group B Experience.
Chahinian AP; Comis RL; Maurer LH; Pajak TF
Bull Cancer; 1982; 69(1):79-82. PubMed ID: 6280794
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the results of chemotherapy in squamous cell bronchial carcinoma].
Nagorni-Obradović L
Med Pregl; 1991; 44(9-10):387-90. PubMed ID: 1806789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
